科研刊物

1              Miller, S. Blood collection in Hong Kong. The New Zealand nursing journal. Kai tiaki 71, 23-24 (1978).

2              Liu, H. W. et al. The reappraisal of dilute tissue thromboplastin inhibition test in the diagnosis of lupus anticoagulant. British journal of haematology 72, 229-234, doi:10.1111/j.1365-2141.1989.tb07687.x (1989).

3              Lin, C. K., Liang, R., Liu, H. W., Tse, P. W. & Chan, G. T. Myelodysplastic syndrome and acquired factor VIII inhibitor with severe subcutaneous haemorrhage. Acta haematologica 85, 206-208, doi:10.1159/000204894 (1991).

4              Lin, C. K., Chu, R., Li, K. B. & Leong, S. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese. Vox sanguinis 62, 98-101, doi:10.1111/j.1423-0410.1992.tb01178.x (1992).

5              Mak, K. H., Voak, D., Chu, R. W., Leong, S. & Chua, K. M. Bv: a distinct category of B sub-group among Chinese blood donors in Hong Kong. Transfusion medicine 2, 129-133, doi:10.1111/j.1365-3148.1992.tb00146.x (1992).

6              Mak, K. H., Yan, K. F., Cheng, S. S. & Yuen, M. Y. Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens. Transfusion 33, 348-351, doi:10.1046/j.1537-2995.1993.33493242645.x (1993).

7              Mak, K. H. et al. A survey of the incidence of Miltenberger antibodies among Hong Kong Chinese blood donors. Transfusion 34, 238-241, doi:10.1046/j.1537-2995.1994.34394196622.x (1994).

8              Bhattacherjee, V. et al. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. The Journal of general virology 76 ( Pt 7), 1737-1748, doi:10.1099/0022-1317-76-7-1737 (1995).

9              Cheng, G. et al. Haemolytic transfusion reactions due to Mi-antibodies; need to include MiltenbergerIII positive cells in pre-transfusion antibody screening in Hong Kong. Clinical and laboratory haematology 17, 183-184 (1995).

10           Lin, C. K., Wong, K. F., Mak, K. H., Yuen, C. M. & Lee, A. W. Hemolytic transfusion reaction due to Rh antibodies detectable only by manual polybrene and polyethylene glycol technique. American journal of clinical pathology 104, 660-662, doi:10.1093/ajcp/104.6.660 (1995).

11           Mak, K. H., Lin, C. K., Ford, D. S., Cheng, G. & Yuen, C. The first example of anti-Gya detected in Hong Kong. Immunohematology / American Red Cross 11, 20-21 (1995).

12           Lin, C. K. et al. First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong. Clinical and laboratory haematology 18, 19-22, doi:10.1111/j.1365-2257.1996.tb00731.x (1996).

13           Lin, C. K. et al. A case of hydrops fetalis, probably due to antibodies directed against antigenic determinants of GP.Mur (Miltenberger class III) cells. Immunohematology / American Red Cross 12, 115-118 (1996).

14           Mak, K. H. et al. Serologic characteristics of H-deficient phenotypes among Chinese in Hong Kong. Transfusion 36, 994-999, doi:10.1046/j.1537-2995.1996.36111297091745.x (1996).

15           Prescott, L. E. et al. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. Journal of medical virology 50, 168-175, doi:10.1002/(SICI)1096-9071(199610)50:2<168::AID-JMV10>3.0.CO;2-I (1996).

16           Lin, C. K. et al. Report on anti-Dib encountered in two Hong Kong Chinese. Immunohematology / American Red Cross 13, 17-19 (1997).

17           Lin, C. K., Mak, K. H., Cheng, C. K. & Yang, C. P. The first case of the p phenotype in a Gurkha Nepalese. Immunohematology / American Red Cross 14, 30-32 (1998).

18           Lin, C. K. et al. Serologic characteristics and clinical significance of Miltenberger antibodies among Chinese patients in Hong Kong. Vox sanguinis 74, 59-60, doi:10.1046/j.1423-0410.1998.7410059.x (1998).

19           Cheng, G. & Lin, C. K. Will transfusion errors due to human factors ever be eliminated? Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine 5, 304-305 (1999).

20           Liu, H. W. et al. Reduction of platelet transfusion- associated sepsis by short-term bacterial culture. Vox sanguinis 77, 1-5, doi:10.1159/000031066 (1999).

21           Engelfriet, C. P. et al. Quality assurance, quality control and accreditation. Vox sanguinis 79, 253-264, doi:10.1046/j.1423-0410.2000.79402531.x (2000).

22           Engelfreit, C. P. et al. The use of the computer cross-match. Vox sanguinis 80, 184-192, doi:10.1046/j.1423-0410.2001.00032.x (2001).

23           Zhong, S. et al. Quantitative and genotypic analysis of TT virus infection in Chinese blood donors. Transfusion 41, 1001-1007, doi:10.1046/j.1537-2995.2001.41081001.x (2001).

24           Lau, J. T., Thomas, J. & Lin, C. K. HIV-related behaviours among voluntary blood donors in Hong Kong. AIDS care 14, 481-492, doi:10.1080/09540120208629667 (2002).

25           Lee, C. K. et al. Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. Vox sanguinis 83, 204-208, doi:10.1046/j.1423-0410.2002.00219.x (2002).

26           Lin, C. K. Response 20. Vox sanguinis 82, 87-111, doi:10.1046/j.0042-9007.2001.00147_5.x (2002).

27           Reesink, H. W. et al. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening? Vox sanguinis 83, 72-87, doi:10.1046/j.1423-0410.2002.t01-1-01851.x (2002).

28           Engelfriet, C. P. et al. The future use of pathogen-inactivated platelet concentrates. Vox sanguinis 85, 54-66, doi:10.1046/j.1423-0410.2003.00315.x (2003).

29           Georgsen, J. International Forum: 5. Vox sanguinis 85, 229-230, doi:10.1046/j.1423-0410.2003.0033525.x (2003).

30           Lee, C. K. et al. Estimation of bacterial risk in extending the shelf life of PLT concentrates from 5 to 7 days. Transfusion 43, 1047-1052, doi:10.1046/j.1537-2995.2003.00456.x (2003).

31           Lee, C. K. et al. Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001. Transfusion medicine 13, 227-231, doi:10.1046/j.1365-3148.2003.00445.x (2003).

32           Lin, C. K., Tsoi, W. C. & Lee, C. K. International Forum: 7. Vox sanguinis 85, 232-233, doi:10.1046/j.1423-0410.2003.003527.x (2003).

33           Li, C. K. et al. Unrelated umbilical cord blood transplantation in children: experience of the Hong Kong Red Cross Blood Transfusion Service. Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine 10, 89-95 (2004).

34           Lin, C. K. Practical approaches to limited resources. Vox sanguinis 87 Suppl 2, 172-175, doi:10.1111/j.1741-6892.2004.00502.x (2004).

35           Coste, J. et al. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox sanguinis 88, 289-303, doi:10.1111/j.1423-0410.2005.00636_1.x (2005).

36           Lee, C. K. et al. Prevention of transfusion-transmitted hepatitis E by donor-initiated self exclusion. Transfusion medicine 15, 133-135, doi:10.1111/j.0958-7578.2005.00563.x (2005).

37           Yu, P. L., Chung, K. H., Lin, C. K., Chan, J. S. & Lee, C. K. Predicting potential drop-out and future commitment for first-time donors based on first 1.5-year donation patterns: the case in Hong Kong Chinese donors. Vox sanguinis 93, 57-63, doi:10.1111/j.1423-0410.2007.00905.x (2007).

38           Lee, C. K. et al. Value of anaerobic culture in bacterial surveillance program for platelet concentrates. Transfusion 48, 2606-2611, doi:10.1111/j.1537-2995.2008.01887.x (2008).

39           Lee, C. K., Hong, J. & Hung, A. T. An update of blood donor recruitment and retention in Hong Kong. Asian journal of transfusion science 2, 47-50, doi:10.4103/0973-6247.42691 (2008).

40           Reesink, H. W. et al. Donors with a rare pheno (geno) type. Vox sanguinis 95, 236-253, doi:10.1111/j.1423-0410.2008.01084.x (2008).

41           Lin, C. K. & Thomas, S. Cost-effectiveness of blood programmes - the Asia Pacific Blood Network perspective. ISBT Science Series 4, 332-336, doi:10.1111/j.1751-2824.2009.01263.x (2009).

42           Devine, D. V. et al. Inventory management. Vox sanguinis 98, e295-363, doi:10.1111/j.1423-0410.2009.01252.x (2010).

43           Hung, I. F. et al. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 51, 274-279, doi:10.1086/653940 (2010).

44           Leung, V. K. et al. A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. Transfusion medicine 20, 276-277, doi:10.1111/j.1365-3148.2010.00997.x (2010).

45           Reesink, H. W. et al. Haemovigilance for the optimal use of blood products in the hospital. Vox sanguinis 99, 278-293, doi:10.1111/j.1423-0410.2010.01323.x (2010).

46           Tadokoro, K. et al. Problems with irradiators. Vox sanguinis 98, 78-84, doi:10.1111/j.1423-0410.2009.01244.x (2010).

47           Wong, H. K. et al. Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion 50, 1967-1971, doi:10.1111/j.1537-2995.2010.02651.x (2010).

48           Wu, J. T., Lee, C. K., Cowling, B. J. & Yuen, K. Y. Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proceedings of the National Academy of Sciences of the United States of America 107, 3269-3274, doi:10.1073/pnas.0911596107 (2010).

49           Yuen, M. F. et al. Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population. Gut 59, 1389-1393, doi:10.1136/gut.2010.209148 (2010).

50           Benjamin, R. J. et al. Deferral of males who had sex with other males. Vox sanguinis 101, 339-367, doi:10.1111/j.1423-0410.2011.01489.x (2011).

51           Hong, J. & Loke, A. Y. Hong Kong young people's blood donation behavior. Asian journal of transfusion science 5, 49-52, doi:10.4103/0973-6247.76000 (2011).

52           Hung, I. F. et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 52, 447-456, doi:10.1093/cid/ciq106 (2011).

53           Lee, C. K. Bacterial contamination of blood products. ISBT Science Series 6, 427-431, doi:10.1111/j.1751-2824.2011.01527.x (2011).

54           Lee, C. K. Application of quality principles in transfusion microbiology. ISBT Science Series 6, 284-286, doi:10.1111/j.1751-2824.2011.01534.x (2011).

55           Lin, C. K. Harmonization in donor management - the Asia-Pacific perspective. ISBT Science Series 6, 377-380, doi:10.1111/j.1751-2824.2011.01539.x (2011).

56           Qin, Y. Y. et al. Halogenated POPs and PAHs in blood plasma of Hong Kong residents. Environmental science & technology 45, 1630-1637, doi:10.1021/es102444g (2011).

57           Wu, J. T. et al. Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med 8, e1001103, doi:10.1371/journal.pmed.1001103 (2011).

58           Wu, J. T., Lee, C. K., Cowling, B. J. & Yuen, K. Y. Logistical feasibility and potential benefits of a population-wide passive immunotherapy program during an influenza pandemic. Influenza Other Respir Viruses 5, 226-229 (2011).

59           Yuen, M. F. et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 52, 624-632, doi:10.1093/cid/ciq247 (2011).

60           Cheng, C. K., Lee, C. K. & Lin, C. K. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 52, 2220-2224, doi:10.1111/j.1537-2995.2012.03570.x (2012).

61           Lee, C. K. et al. Significant bacterial contamination risk reduction with the use of diversion pouch. Transfusion medicine 22, 404-408, doi:10.1111/j.1365-3148.2012.01194.x (2012).

62           Reesink, H. W. et al. Measures to prevent transfusion-related acute lung injury (TRALI). Vox sanguinis 103, 231-259, doi:10.1111/j.1423-0410.2012.01596.x (2012).

63           Roth, W. K. et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox sanguinis 102, 82-90, doi:10.1111/j.1423-0410.2011.01506.x (2012).

64           Stormer, M. et al. Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria. Vox sanguinis 102, 22-31, doi:10.1111/j.1423-0410.2011.01510.x (2012).

65           Wong, H. K., Lee, C. K., Leung, J. N., Tsoi, W. C. & Lin, C. K. Risk factor analysis of hepatitis C virus infection among Chinese blood donors in Hong Kong. Transfusion medicine 22, 133-136, doi:10.1111/j.1365-3148.2011.01128.x (2012).

66           Chan, H. M., Ho, P. L., Chan, K. H., Lin, C. K. & Lee, C. K. Interdiction of a blood donation containing varicella-zoster virus by donor self-report of chickenpox. Vox sanguinis 104, 248-249, doi:10.1111/j.1423-0410.2012.01655.x (2013).

67           Fung, J. et al. Defining normal liver stiffness range in a normal healthy Chinese population without liver disease. PloS one 8, e85067, doi:10.1371/journal.pone.0085067 (2013).

68           Hung, I. F. N. et al. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest 144, 464-473, doi:10.1378/chest.12-2907 (2013).

69           Lau, E. H., He, X. Q., Lee, C. K. & Wu, J. T. Predicting future blood demand from thalassemia major patients in Hong Kong. PloS one 8, e81846, doi:10.1371/journal.pone.0081846 (2013).

70           Lee, C. K. et al. Long-term clinical outcomes after Streptococcus bovis isolation in asymptomatic blood donors in Hong Kong. Transfusion 53, 2207-2210, doi:10.1111/trf.12087 (2013).

71           Lee, C. K., Lee, K. C., Lin, C. K. & Lee, S. S. Donors' perspectives on self-deferral of men having sex with men from blood donation. Transfusion 53, 2441-2448, doi:10.1111/trf.12365 (2013).

72           Lee, C. K. et al. A study of the predonation hemoglobin and iron status among Hong Kong Chinese blood donors. Transfusion 53, 322-327, doi:10.1111/j.1537-2995.2012.03788.x (2013).

73           Poon, C. M., Lee, S. S. & Lee, C. K. Variation of motivation between weekday and weekend donors and their association with distance from blood donation centres. Transfusion medicine 23, 152-159, doi:10.1111/tme.12034 (2013).

74           Reesink, H. W. et al. The use of the electronic (computer) cross-match. Vox sanguinis 104, 350-364, doi:10.1111/vox.12003 (2013).

75           Tsoi, W. C., Lelie, N. & Lin, C. K. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Transfusion 53, 2477-2488, doi:10.1111/trf.12165 (2013).

76           Wong, D. K. et al. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PloS one 8, e66920, doi:10.1371/journal.pone.0066920 (2013).

77           Wong, H. K., Lee, C. K., Leung, J. N., Lee, I. Y. & Lin, C. K. Reduction in vasovagal reaction rate in young first-time blood donors by collecting 350 mL rather than 450 mL. Transfusion 53, 2763-2765, doi:10.1111/trf.12134 (2013).

78           Wu, S. P. et al. MGUS prevalence in an ethnically Chinese population in Hong Kong. Blood 121, 2363-2364, doi:10.1182/blood-2012-11-466011 (2013).

79           Huang, F. Y. et al. Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection. PloS one 9, e99028, doi:10.1371/journal.pone.0099028 (2014).

80           Lieberman, L. et al. Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care. Vox sanguinis 107, 276-311, doi:10.1111/vox.12103 (2014).

81           Lin, C. K., Leung, J. N. S., So, B. K. L. & Lee, C. K. Donor selection for blood safety: is it still necessary? ISBT Science Series 9, 26-29, doi:10.1111/voxs.12056 (2014).

82           Lin, C. K., So, B. K. L., Leung, J. N. S., Wong, H. K. & Lee, C. K. Current issues in donor health and safety. ISBT Science Series 9, 223-227, doi:10.1111/voxs.12061 (2014).

83           Pietersz, R. N. et al. Bacterial contamination in platelet concentrates. Vox sanguinis 106, 256-283, doi:10.1111/vox.12098 (2014).

84           So, B. K. et al. Evaluation of two chlorhexidine-alcohol-based skin disinfectants in blood donation setting. Vox sanguinis 106, 316-321, doi:10.1111/vox.12107 (2014).

85           Kwok, J. et al. Factors Influencing Hematopoietic Stem Cell Donation Intention in Hong Kong: A Web-Based Survey. Annals of transplantation : quarterly of the Polish Transplantation Society 20, 604-613, doi:10.12659/AOT.894165 (2015).

86           Ou, Y. et al. Donation frequency and its association with demographic characteristics--a 1-year observational study. Transfusion medicine 25, 366-373, doi:10.1111/tme.12267 (2015).

87           van der Meer, P. F. et al. Aggregates in platelet concentrates. Vox sanguinis 108, 96-100, doi:10.1111/vox.12184 (2015).

88           Wong, H. T., Lee, S. S., Lee, C. K. & Chan, D. P. Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors. Transfusion 55, 2175-2183, doi:10.1111/trf.13106 (2015).

89           Goldman, M. et al. International Forum regarding practices related to donor haemoglobin and iron. Vox sanguinis 111, 449-455, doi:10.1111/vox.12431 (2016).

90           Kwok, J. et al. HLA-A, -B and -DRB1 genotyping and haplotype frequencies of 3892 cord blood units in the Hong Kong Chinese Cord Blood Registry. Hum Immunol 77, 1109-1110, doi:10.1016/j.humimm.2016.10.006 (2016).

91           Kwok, J. et al. HLA-A, -B, -C, and -DRB1 genotyping and haplotype frequencies for a Hong Kong Chinese population of 7595 individuals. Hum Immunol 77, 1111-1112, doi:10.1016/j.humimm.2016.10.005 (2016).

92           Lee, C. K. Update on donor recruitment and management in blood service. ISBT Science Series 11, 69-72, doi:10.1111/voxs.12265 (2016).

93           Tsoi, W. C. Advances in blood storage bags and preservative solutions. ISBT Science Series 11, 49-54, doi:10.1111/voxs.12240 (2016).

94           Wong, D. K. et al. Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 22, 290 e291-293, doi:10.1016/j.cmi.2015.10.036 (2016).

95           Cheung, K. F. et al. Annexin II-binding immunoglobulins in patients with lupus nephritis and their correlation with disease manifestations. Clin Sci (Lond) 131, 653-671, doi:10.1042/CS20160732 (2017).

96           Han, L. et al. Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status. Lung Cancer 114, 79-89, doi:10.1016/j.lungcan.2017.10.012 (2017).

97           Kwok, J. et al. Estimation of optimal donor number in Bone Marrow Donor Registry: Hong Kong's experience. Hum Immunol 78, 610-613, doi:10.1016/j.humimm.2017.08.007 (2017).

98           Lee, S., Cheung, E., Leung, J. & Lee, C. Non‐compliance to infectious disease deferral criteria among Hong Kong's blood donors. Vox sanguinis 112, 425-433 (2017).

99           Lee, S. S., Cheung, E. K. H., Leung, J. N. S. & Lee, C. K. Non-compliance to infectious disease deferral criteria among Hong Kong's blood donors. Vox sanguinis 112, 425-433, doi:10.1111/vox.12520 (2017).

100         Lelie, N. et al. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing. Transfusion 57, 24-35, doi:10.1111/trf.13819 (2017).

101         Sharma, R. R. et al. Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections. Vox sanguinis 112, e1-e21, doi:10.1111/vox.12508 (2017).

102         Sharma, R. R. et al. Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections: summary. Vox sanguinis 112, 388-396, doi:10.1111/vox.12469 (2017).

103         Wong, W. S., Wong, K. F., Kwok, J., Tsoi, W. C. & Leung, J. N. A life-threatening transfusion reaction. Transfusion 57, 2076, doi:10.1111/trf.14051 (2017).

104         Cheng, V. C. C. et al. Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, China. Emerging infectious diseases 24, 49-57, doi:10.3201/eid2401.171297 (2018).

105         Corash, L. et al. A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness. Blood 132, 1257-1257, doi:10.1182/blood-2018-99-112305 (2018).

106         Kwok, J. et al. Simulation of non-inherited maternal antigens acceptable HLA mismatches to increase the chance of matched cord blood units: Hong Kong's experience. Hum Immunol 79, 539-544, doi:10.1016/j.humimm.2018.04.004 (2018).

107         Lau, C., Lee, C. & Association, o. b. o. t. T. F. o. A. o. t. H. K. M. in Hong Kong Medical Association CME Bulletin    2 - 8 (2018).

108         Mak, L. Y. et al. Joint recommendations on management of anaemia in patients with gastrointestinal bleeding in Hong Kong. Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine 24, 416-422, doi:10.12809/hkmj187348 (2018).

109         Tam, K. et al. A study of human neutrophil antigen genotype frequencies in Hong Kong. Transfusion medicine 28, 310-318, doi:10.1111/tme.12494 (2018).

110         Wong, A., Yuen, Y. K. & Lee, C. K. Preparing your blood centre for accreditation. ISBT Science Series 13, 279-283, doi:10.1111/voxs.12413 (2018).

111         Wong, H.-k. et al. Vasovagal reaction in blood donors: prediction and its impact on donor return. ISBT Science Series 13, 421-428, doi:10.1111/voxs.12442 (2018).

112         Wong, N. S. et al. Prevalence of hepatitis C infection and its associated factors in healthy adults without identifiable route of transmission. Journal of viral hepatitis 25, 161-170, doi:10.1111/jvh.12804 (2018).

113         Leung, K., Lee, C. K., Lau, E. H. Y., Lau, C. W. & Wu, J. T. Assessing the impact of respiratory infections and weather conditions on donor attendance and blood inventory in Hong Kong. Vox sanguinis 114, 137-144, doi:10.1111/vox.12745 (2019).

114         Ng, S. C. et al. Streptococcus bovis bacteraemia should be investigated for early detection of colorectal pathology. Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine 25, 414, doi:10.12809/hkmj198135 (2019).

115         Seed, C. R. et al. International Forum on Occult hepatitis B infection and transfusion safety. Vox sanguinis 114, e1-e35, doi:10.1111/vox.12743 (2019).

116         Sim, J. et al. Transfusion of pathogen-reduced platelet components without leukoreduction. Transfusion 59, 1953-1961, doi:10.1111/trf.15269 (2019).

117         Wong, H. K., Ho, P. L. & Lee, C. K. Streptococcus gallolyticus Bacteremia and Colorectal Carcinoma. Gastroenterology 156, 291-292, doi:10.1053/j.gastro.2018.07.059 (2019).

118         Chow, Y. F. et al. Hong Kong Society of Clinical Blood Management recommendations for implementation of patient blood management. Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine 26, 331-338, doi:10.12809/hkmj208397 (2020).

119         Kwok, J. et al. High resolution allele genotyping and haplotype frequencies for NGS based HLA 11 loci of 5266 Hong Kong Chinese bone marrow donors. Hum Immunol 81, 577-579, doi:10.1016/j.humimm.2020.08.005 (2020).

120         Kwok, J. et al. HLA-DQB1, -DQA1, -DPB1, and -DPA1 genotyping and haplotype frequencies for a Hong Kong Chinese population of 1064 individuals. Hum Immunol 81, 3-5, doi:10.1016/j.humimm.2019.11.005 (2020).

121         Kwok, J. et al. HLA-DQB1, -DQA1, -DPB1, and -DPA1 genotyping and haplotype frequencies for a Hong Kong Chinese population of 1064 individuals. Hum Immunol 81, 3-5, doi:10.1016/j.humimm.2019.11.005 (2020).

122         Lau, J. Y. C. et al. Compliance of donors following a two-phased implementation of 12-month deferral of men who have sex with men in Hong Kong. International Journal of Infectious Diseases 101, 302, doi:10.1016/j.ijid.2020.09.789 (2020).

123         Lee, C. K. Impact of severe acute respiratory syndrome on blood services and blood in Hong Kong in 2003. Transfusion medicine 30, 169-171, doi:10.1111/tme.12698 (2020).

124         Leung, J. N. S. & Lee, C.-K. Impact of the

 COVID

 ‐19 – a regional blood centre's perspective. ISBT Science Series 15, 362-364, doi:10.1111/voxs.12558 (2020).

125         Shander, A. et al. Essential Role of Patient Blood Management in a Pandemic: A Call for Action. Anesth Analg 131, 74-85, doi:10.1213/ANE.0000000000004844 (2020).

126         Tsoi, W. C., Zhu, X., To, A. P. & Holmberg, J. Hepatitis E virus infection in Hong Kong blood donors. Vox sanguinis 115, 11-17, doi:10.1111/vox.12846 (2020).

127         Wong, H. K. & Lee, C. K. Pivotal role of convalescent plasma in managing emerging infectious diseases. Vox sanguinis 115, 545-547, doi:10.1111/vox.12927 (2020).

128         Zhang, Y. et al. Harnessing the potential of blood donation archives for influenza surveillance and control. PloS one 15, e0233605, doi:10.1371/journal.pone.0233605 (2020).

129         Al-Riyami, A. Z. et al. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses. Vox sanguinis 116, e71-e120, doi:10.1111/vox.13114 (2021).

130         Al-Riyami, A. Z. et al. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary. Vox sanguinis 116, 1117-1135, doi:10.1111/vox.13113 (2021).

131         Bloch, E. M. et al. Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries. Vox sanguinis 116, 18-35, doi:10.1111/vox.12970 (2021).

132         Chan, K. Y. Y. et al. R4 RGS proteins suppress engraftment of human hematopoietic stem/progenitor cells by modulating SDF-1/CXCR4 signaling. Blood Adv 5, 4380-4392, doi:10.1182/bloodadvances.2020003307 (2021).

133         Cheung, C. H. Y. et al. Effects of Performing Applied Muscle Tension during Recovery after Phlebotomy in Young, First-Time Donors: A Pilot Study. Int J Environ Res Public Health 18, 10541, doi:10.3390/ijerph181910541 (2021).

134         Feng, J. et al. Double-unit unrelated cord blood transplantation for thalassemia major: Comparison with HLA-identical sibling bone marrow transplantation. Pediatr Transplant 25, e13901, doi:10.1111/petr.13901 (2021).

135         Goldman, M. et al. International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses. Vox sanguinis 116, e1-e24, doi:10.1111/vox.13038 (2021).

136         Ho, J. C. Y. et al. Revisit of Optimal Donor Number Estimation in the Hong Kong Bone Marrow Donor Registry. Front Immunol 12, 638253, doi:10.3389/fimmu.2021.638253 (2021).

137         Lau, J. Y. et al. Compliance and attitudes of blood donors following transitioning from permanent to 12-month deferral of men who have sex with men in Hong Kong. Vox sanguinis 116, 504-512, doi:10.1111/vox.13025 (2021).

138         Lee, C. K. et al. Absence of SARS-CoV-2 viraemia in a blood donor with COVID-19 post-donation. Transfusion medicine 31, 223-224, doi:10.1111/tme.12724 (2021).

139         Mai, Z. M. et al. Low vitamin D exposure and risk of nasopharyngeal carcinoma: Observational and genetic evidence from a multicenter case-control study. Clin Nutr 40, 5180-5188, doi:10.1016/j.clnu.2021.07.034 (2021).

140         Ng, S. C. et al. Role of donor self-reporting in securing blood safety during COVID-19 pandemic. Transfusion medicine 31, 213-214, doi:10.1111/tme.12747 (2021).

141         Prax, M. et al. Establishment of transfusion-relevant bacteria reference strains for red blood cells. Vox sanguinis 116, 692-701, doi:10.1111/vox.13057 (2021).

142         Wendel, S. et al. Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic. Vox sanguinis 116, 872-879, doi:10.1111/vox.13096 (2021).

143         Yu, K. Y. et al. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis. Lupus 30, 1039-1050, doi:10.1177/09612033211004727 (2021).

144         Yu, K. Y. C. et al. Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis. Rheumatology (Oxford) 60, 737-750, doi:10.1093/rheumatology/keaa370 (2021).

145         Yung, Y. L. et al. Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients. HLA 97, 127-132, doi:10.1111/tan.14135 (2021).

146         Al-Riyami, A. Z. et al. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic. Vox sanguinis 117, 822-830, doi:10.1111/vox.13256 (2022).

147         Chan, L. K. L. et al. Provision of human leukocyte antigen (HLA) selected platelets: 10-year experience of a regional blood centre. Annals of Blood (2022).

148         Chui, C. S. L. et al. Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study. EClinicalMedicine 50, 101504, doi:10.1016/j.eclinm.2022.101504 (2022).

149         Fung, Y. L. et al. The contribution and potential of older blood donors in Asia Pacific regions. Transfusion medicine 32, 71-76, doi:10.1111/tme.12845 (2022).

150         Kwok, S. L. et al. Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021. Euro Surveill 27, 2101197, doi:10.2807/1560-7917.ES.2022.27.2.2101197 (2022).

151         Lee, C. K. Reflection from managing blood supply during social unrest. Transfusion medicine 32, 180-181, doi:10.1111/tme.12832 (2022).

152         Pandey, S. et al. International Forum on Gender Identification and Blood Collection: Responses. Vox sanguinis 117, E21-E43, doi:10.1111/vox.13193 (2022).

153         Pandey, S. et al. International Forum on Gender Identification and Blood Collection: Summary. Vox sanguinis 117, 447-456, doi:10.1111/vox.13192 (2022).

154         Wan, E. Y. F. et al. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis 22, 64-72, doi:10.1016/S1473-3099(21)00451-5 (2022).

155         Wong, C. K. H. et al. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization. BMC Med 20, 119, doi:10.1186/s12916-022-02321-4 (2022).

156         Wong, N. S., Lau, L. H. W., Chan, D. P. C., Lee, C. K. & Lee, S. S. Low level of dengue infection and transmission risk in Hong Kong: an integrated analysis of temporal seroprevalence results and corresponding meteorological data. Int J Environ Health Res, 1-12, doi:10.1080/09603123.2022.2149709 (2022).

157         Aquino, Y. et al. Dissecting human population variation in single-cell responses to SARS-CoV-2. Nature, doi:10.1038/s41586-023-06422-9 (2023).

158         Cheung, Y. T. et al. Iron Deficiency among School-Aged Adolescents in Hong Kong: Prevalence, Predictors, and Effects on Health-Related Quality of Life. International Journal of Environmental Research and Public Health 20, 2578 (2023).

159         Lau, J. J. et al. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nat Med 29, 348-357, doi:10.1038/s41591-023-02219-5 (2023).

160         Lee, C., Lee, I. M., Chu, C. Y., Wong, N. & Leung, L. A survey of Chinese regular blood donors who were enrolled into an iron replenishment program – A hint for dietary factors. Global Journal of Transfusion Medicine 8, 28-33, doi:10.4103/gjtm.gjtm_15_22 (2023).

161         Ng, S. C. et al. Re-examine the transfusion transmitted risk of SARS-CoV-2 virus during a major COVID-19 outbreak in 2022. Transfusion medicine 33, 315-319, doi:10.1111/tme.12981 (2023).

162         Shander, A. et al. Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS). Ann Surg 277, 581-590, doi:10.1097/SLA.0000000000005721 (2023).

163         Ye, X. et al. Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. Eur Heart J Cardiovasc Pharmacother 9, 403-412, doi:10.1093/ehjcvp/pvad015 (2023).